What is the address of PharmaPROP.BXL?

The registered office of PharmaPROP.BXL is located at Zavelput 17, 1000 Brussel.

Is PharmaPROP.BXL still active?

Yes. According to the CBE (28 September 2026) PharmaPROP.BXL is active, legal situation “Normale toestand”, started on 8 August 2023.

Is PharmaPROP.BXL registered on Peppol?

Yes, PharmaPROP.BXL is registered on the Peppol network with ID 0208:0804643803.

What is the enterprise number of PharmaPROP.BXL?

The enterprise number of PharmaPROP.BXL is BE0804643803.

When was PharmaPROP.BXL founded?

PharmaPROP.BXL was founded on 8 August 2023.

Who are the directors of PharmaPROP.BXL?

According to the 2024 annual accounts, the directors of PharmaPROP.BXL are: PHARMABXL.

Is PharmaPROP.BXL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 August 2023; 1 annual account filed (fiscal year 2024); 1 directors known from the annual account.

How much profit did PharmaPROP.BXL make in 2024?

PharmaPROP.BXL recorded a loss after taxes of € 2,163 in financial year 2024.

What is the revenue of PharmaPROP.BXL?

As a small company, PharmaPROP.BXL is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 50,325.

How many employees does PharmaPROP.BXL have?

According to the 2024 annual accounts, PharmaPROP.BXL has 0 full-time equivalents (FTE).

PharmaPROP.BXL (Private Limited) - Brussel - BE0804643803

Dossier PharmaPROP.BXL, printed on 28 September 2026 from databakkes.be/en/0804643803/pharmaprop-bxl. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 1 of the last 1 fiscal years.
Tight liquidity NBB

Cash and receivables cover 13 % of short-term debt in 2024; threshold 65 %.
Late annual account NBB

Fiscal year 2024 was filed 379 days after the legal deadline.
Annual account missing NBB

Fiscal year 2025 was expected before 30 January 2026 and has not been filed.

Financials

Financial year 2024

PharmaPROP.BXL from Brussel, company number BE0804643803, closed financial year 2024 with a result of € -2,163 after tax. For that financial year PharmaPROP.BXL recorded a gross margin of € 50,325 and equity of € -1,163. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 13, 2026.

What it is worth Caution

€ -1,163

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -2,163

Profit after tax over the fiscal year.

Cash in the bank

€ 7,579

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -2,163.

People and assets in 2024

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2024

Bank debt ≈ 29 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 665,365

€ 23,117 is repaid this year. At this pace the long-term loan is gone in ≈ 29 years.

Owed to suppliers

€ 406

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to PharmaPROP.BXL?

What happened at PharmaPROP.BXL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 13, 2026 New annual accounts for financial year 2024: loss of € 2,163. filed late Source: NBB ↗
Aug 8, 2023 New establishment in Brussel. KBO
Aug 8, 2023 Start of the company according to the CBE. KBO
2023 PHARMABXL became a director. NBB

Original PDFs at the National Bank ↗

A new publication or filing at PharmaPROP.BXL? We notify you, reason included.

Follow PharmaPROP.BXL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit